Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Burger

Showing results (651-660 of 1,155) with videos related to

Pageof 116
Sort By:
Diseases of the Colon and Rectum|February 9, 2013
Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastasesNinos Ayez, Jacobus W A Burger, Anne E van der Pool, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group StudyDavid R Spriggs, Mark F Brady, Luis Vaccarello, et al.
IEEE Transactions on Medical Imaging|August 31, 2022
An Investigation of Stochastic Variance Reduction Algorithms for Relative Difference Penalized 3D PET Image ReconstructionRobert Twyman, Simon Arridge, Zeljko Kereta, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2020
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary TuberculosisAndreas H Diacon, Veronique R De Jager, Rodney Dawson, et al.
Cancer|November 21, 2015
β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemiaPhilip A Thompson, Susan M O'Brien, Lianchun Xiao, et al.
World Journal of Urology|July 22, 2018
Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancerChristian Daniel Fankhauser, Cédric Poyet, Stephanie G C Kroeze, et al.
Gynecologic Oncology|June 21, 2015
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancerIrene A Burger, Debra A Goldman, Hebert Alberto Vargas, et al.
BJR Open|August 26, 2022
Frequency and intensity of [<sup>18</sup>F]-PSMA-1007 uptake after COVID-19 vaccination in clinical PETAlexander Maurer, Helen Schiesser, Stephan Skawran, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2023
Development and external validation of a multivariable [<sup>68</sup>Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancerUrs J Muehlematter, Lilit Schweiger, Daniela A Ferraro, et al.
EJNMMI Research|February 10, 2024
Relaxed fibronectin: a potential novel target for imaging endometriotic lesionsBelinda Trachsel, Stefan Imobersteg, Giulia Valpreda, et al.
Pageof 116

Showing results (651-660 of 1,155) with videos related to

Sort By:
Pageof 116
Diseases of the Colon and Rectum|February 9, 2013
Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastasesNinos Ayez, Jacobus W A Burger, Anne E van der Pool, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2007
Phase III randomized trial of intravenous cisplatin plus a 24- or 96-hour infusion of paclitaxel in epithelial ovarian cancer: a Gynecologic Oncology Group StudyDavid R Spriggs, Mark F Brady, Luis Vaccarello, et al.
IEEE Transactions on Medical Imaging|August 31, 2022
An Investigation of Stochastic Variance Reduction Algorithms for Relative Difference Penalized 3D PET Image ReconstructionRobert Twyman, Simon Arridge, Zeljko Kereta, et al.
Antimicrobial Agents and Chemotherapy|January 29, 2020
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary TuberculosisAndreas H Diacon, Veronique R De Jager, Rodney Dawson, et al.
Cancer|November 21, 2015
β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemiaPhilip A Thompson, Susan M O'Brien, Lianchun Xiao, et al.
World Journal of Urology|July 22, 2018
Current and potential future role of PSMA-PET in patients with castration-resistant prostate cancerChristian Daniel Fankhauser, Cédric Poyet, Stephanie G C Kroeze, et al.
Gynecologic Oncology|June 21, 2015
Incorporation of postoperative CT data into clinical models to predict 5-year overall and recurrence free survival after primary cytoreductive surgery for advanced ovarian cancerIrene A Burger, Debra A Goldman, Hebert Alberto Vargas, et al.
BJR Open|August 26, 2022
Frequency and intensity of [<sup>18</sup>F]-PSMA-1007 uptake after COVID-19 vaccination in clinical PETAlexander Maurer, Helen Schiesser, Stephan Skawran, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2023
Development and external validation of a multivariable [<sup>68</sup>Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancerUrs J Muehlematter, Lilit Schweiger, Daniela A Ferraro, et al.
EJNMMI Research|February 10, 2024
Relaxed fibronectin: a potential novel target for imaging endometriotic lesionsBelinda Trachsel, Stefan Imobersteg, Giulia Valpreda, et al.
Pageof 116